<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792388</url>
  </required_header>
  <id_info>
    <org_study_id>vip</org_study_id>
    <nct_id>NCT01792388</nct_id>
  </id_info>
  <brief_title>Vitd and Barrier Function in IBD</brief_title>
  <acronym>VIP</acronym>
  <official_title>Vitamin D and Its Effects on Inflammation and Intestinal Permeability in Crohn's Disease in Remission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dublin, Trinity College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Dublin, Trinity College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased Intestinal Permeability is detectable in clinically active Crohn's disease, in
      stable Crohn's disease and is predictive of clinical relapse. Maintenance of the epithelial
      barrier integrity is therefore essential for intestinal homeostasis. Vitamin D may have a
      critical role in improving barrier function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Intestinal Permability from baseline and 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Lactulose, Mannitol, Sucralose Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Inflammatory and antimicrobial peptide levels from baseline to 3 months</measure>
    <time_frame>Baseline and 3months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess change in grip strength and associated fatigue markers</measure>
    <time_frame>Baseline and 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Crohn's Disease</condition>
  <arm_group>
    <arm_group_label>Soya Bean oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Capsule Form</description>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Soya Bean oil</intervention_name>
    <description>Capsule form</description>
    <arm_group_label>Soya Bean oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients must fulfill the clinical criteria for diagnosis of CD as defined by
             Lennard-Jones et al. (1976)

          -  All patients must be in clinical remission for at least 1 month at study entry as
             defined by a Crohn's Disease Activity Index (CDAI) of &lt;150

          -  18-65 years

          -  Patients on stable drug therapies for at least 1 month pre-enrolment

          -  Sufficient English language ability to carry out the study requirements

        Exclusion Criteria:

          -  Symptomatic CD at study entry including CDAI &gt;150

          -  Pregnancy

          -  Previous extensive small bowel resection (less than 200 cm of viable small bowel or a
             loss of 50% or more of the small intestine)

          -  Presence of an ileostomy or colostomy

          -  Known hypersensitivity to vitamin D

          -  Hypercalcaemia (corrected serum calcium &gt; 2.66 mmol/L)

          -  Those currently using supplemental vitamin D &gt;800 IU/D

          -  Diagnosis of any of the following: active tuberculosis, sarcoidosis,
             hyperparathyroidism, renal failure, pseudohyperparathyroidism, malignancy, active,
             lymphoma, short bowel syndrome

          -  Antibiotic use in the 4 weeks prior to enrolment

          -  Current use of bisphosphonates

          -  Renal Impairment, Diabetes Mellitus

          -  Patients participating in a concurrent RCT

          -  Alcohol dependency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria O'Sullivan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trinity College Dublin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tallaght Hospital</name>
      <address>
        <city>Dublin 24</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Adelaide and Meath Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2012</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>July 21, 2014</last_update_submitted>
  <last_update_submitted_qc>July 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Dublin, Trinity College</investigator_affiliation>
    <investigator_full_name>Tara Raftery</investigator_full_name>
    <investigator_title>Dr. Maria O'Sullivan, PhD</investigator_title>
  </responsible_party>
  <keyword>Crohn's Disease</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Intestinal Permeability</keyword>
  <keyword>Tara Raftery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

